Activation of iNKT cells with the CD1d-binding glycolipid adjuvant a-galactosylceramide (a-GC) enhances humoral immunity specific for coadministered T-dependent Ag. However, the relationship between the iNKT cell and the classic T helper (Th) or T follicular helper (Tfh) function following this immunization modality remains unclear. We show that immunization with the C-terminal domain (CTD) of Clostridium difficile toxin B (TcdB), accompanied by activation of iNKT cells with a-GC, led to enhanced production of CTD-specific IgG, which was CD1d-and iNKT cell-dependent and associated with increased neutralization of active TcdB. Immunization with CTD plus a-GC followed by NP hapten-linked CTD increased NPspecific IgG1 titers in an NKT-dependent manner, suggesting that iNKT activation could enhance Th or Tfh function or that iNKT and iNKTfh cells could provide supplemental, yet independent, B cell help. Th, Tfh, iNKT, and iNKTfh cells were, therefore, examined quantitatively, phenotypically, and functionally following immunization with CTD or with CTD plus a-GC. Our results demonstrated that a-GC-activated iNKT cells had no direct effect on the numbers, phenotype, or function of Th or Tfh cells. However, CD4 + T cell-specific ablation of the Bcl6 transcription factor demonstrated that Tfh and iNKTfh cells both contributed to B cell help. This work extends our understanding of the immune response to vaccination and demonstrates an important contribution by NKTfh cells to humoral immunity.
Introduction
Semi-invariant TCR-bearing iNKT cells respond to CD1d presentation of glycolipids and related molecules. Activation of iNKT cells can be stimulated by CD1d presentation of foreign and self-glycolipids [1] [2] [3] . iNKT cells activated by the foreign glycolipid a-GC shape and enhance protective humoral immunity against bacterial toxins and infectious agents [4] [5] [6] [7] [8] .
Activation of iNKT cells with a-GC at the time of immunization with a T dependent Ag enhances generation of Ag-specific memory B cells and long-lived plasma cells [7, 9, 10] . The adjuvant effect of a-GC is well established to be CD1d-and iNKTdependent [4, 11, 12] and to be at least comparable with standard adjuvants, such as Alum and TLR ligands [9] .
The mechanisms by which a-GC-activated iNKT cells enhance humoral immunity against T dependent Ags are not well understood. Receptor-dependent (cognate) and soluble effectormediated (noncognate) interactions likely contribute to B cell help [13] . CD1d expression by B cells and DCs is required for iNKT cell-enhanced Ab production, demonstrating the requirement for a direct CD1d/TCR interaction [6, 12] . Costimulatory molecule signaling lymphocyte activation molecule-associated protein is also contributory to iNKT cellenhanced Ab production [14] . In contrast, CD40L expression by iNKT cells is dispensable for enhanced humoral immune responses [15] . iNKT cell-derived BAFF and a proliferationinducing ligand (APRIL) contribute to plasma cell longevity [16] , whereas iNKT cell-derived IL-4 and IFN-g exert minimal effects on Ab production or Ig class switch [17] . However, dispensable iNKT-derived effectors (CD40L, IL-4, IFN-g) must still be provided by classic T lineage cells during an iNKTenhanced humoral response.
Tfh cells, a Th subset, provide help to B cells. Tfh cells are defined by expression of the transcription factor Bcl-6; cell surface expression of CD44, CXCR5, PD-1, and ICOS; and IL-21 secretion [18] . Tfh cells are vital for formation and maintenance of germinal centers and for differentiation of activated B cells into plasma cells and memory B cells [18] . Recently a subset of iNKT cells, known as iNKTfh cells, was discovered [19] . Like Tfh cells, iNKTfh cells express Bcl-6, CD44, CXCR5, PD-1, ICOS, and IL-21 [19] [20] [21] . However, it is not well understood whether iNKTfh cells directly contribute to the B cell response to protein antigens.
Prior studies suggested that a-GC-activated iNKT cells lead to priming of Th cells [7, 11] . Immunization with a T dependent Ag alone or an Ag plus a-GC was followed by boosting with a haptenconjugated Ag. Anti-hapten IgG responses were greater in mice that received a-GC, raising the intriguing possibility that iNKT activation primed Th and Tfh function. However, that effect could also have been due to prolonged activation of iNKT or iNKTfh cells.
Clostridium difficile is the leading cause of hospital-acquired infections, antibiotic-associated diarrhea, and pseudomembranous colitis ( [22] ) and is associated with systemic disease in animal models [23] . Although large-scale epidemiologic studies are lacking, systemic complications in patients include multiple organ failure ( [24] ). TcdA-and TcdB-specific serum IgG responses are correlates of protection against C. difficile infection [25] [26] [27] . However, the contribution of iNKT cells to the humoral immune response to C. difficile toxins has not been established. Because TcdB is a highly relevant candidate vaccine Ag, it was selected as the immunization Ag for this study.
In this study, we used in vivo and ex vivo approaches, adoptive transfers, and lineage-specific gene ablation to test the hypothesis that Th cells, iNKT cells, and their follicular helper subsets coordinate to enhance humoral immunity to TcdB, a T dependent protein Ag. We show that Th, Tfh, iNKT, and iNKTfh cells contribute to TcdB-neutralizing Ab responses. Furthermore, although the iNKT/iNKTfh and Th/Tfh arms of the responses complement each other, activation of iNKT/iNKTfh cells with a-GC does not lead directly to effects on Th/Tfh numbers or functions. These findings advance our understanding of the various forms of T lineage help that are brought to bear on the humoral immune response following vaccination with T dependent Ag and a-GC adjuvant.
MATERIALS AND METHODS

Ethics
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the U. S. National Institutes of Health. All animal procedures were approved by the OUHSC Institutional Animal Care and Use Committee (protocol 14-111).
Reagents
PBS57-loaded and unloaded CD1d tetramers were provided by the NIAID Tetramer Facility (Emory University, Atlanta, GA, USA). Other reagents were purchased as follows: anti-CD1d (1B1), anti-CD44 (IM7), anti-CXCR5 (2G8), anti-TCR-b (H57-597), anti-CD4 (RM4-5), anti-IL-4, and streptavidin (BD Biosciences, San Jose, CA, USA); anti-PD-1 (J43) mAb (eBioscience, San Diego, CA, USA); anti-B220 (RA3-6B2) and anti-CD8a (53-6.7) (Tonbo Biosciences, San Diego, CA, USA); anti-Cre (d7L7L) (Cell Signaling Technology, Danvers, MA, USA); anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA, USA); anti-PE and anti-APC microbeads (Miltenyi Biotec, Auburn, CA, USA); streptavidin-PECF594 (BD Biosciences); a-GC (Axorra, Farmingdale, NY, USA); 2,29-azino-bis (3-ethylbenzothiazoline-6- 
Protein to hapten conjugation
Five hundred micrograms of NP-OH at a concentration of 1 mg/ml was dissolved in PBS (pH 4.5) and added to 500 mg of CTD at a concentration of 1 mg/ml. One hundred microliters of cross-linker at a concentration of 2.5 mg/ml was then mixed with the NP-OH/CTD solution and shaken for 2 h. The NP-CTD conjugate was then purified using a mini Slide-a-Lyzer kit (Pierce Biotechnology) and dialyzed against PBS (pH 7.2) for 2 h with orbital shaking. The dialysis buffer was changed twice, and the shaking process was repeated twice. The NP-conjugate CTD was stored at 220°C until required. [21] ). Unloaded CD1d tetramer lacking ligand was also used to confirm specificity of iNKT cell detection.
ELISA
Immulon 4 ELISA-plates (Dynex Technologies, Chantilly, VA, USA) were coated with CTD, and specific-endpoint IgG1, IgG2b, and IgG2c titers were determined, as described previously [39] .
In vitro neutralization
CHO cells (5 3 10 4 in 100 ml of medium: F-12K, 4 mM L-glutamine, 10% FCS)
were seeded into 96-well plates and cultured overnight (5% CO 2 , 37°C). Sera from naive and immunized mice were diluted 1/500 in medium and mixed with TcdB (2.5 nM final concentration unless indicated otherwise) and incubated for 1 h at room temperature. The concentration of TcdB was previously calibrated to cause 85-95% CHO cell death. The medium was removed from cell cultures and replaced with the sera/toxin/media mixture. Plates were cultured for 24 h before addition of Cell Counting Kit-8 reagent (Dojindo Molecular Technologies, Rockville, MD, USA) and an additional 2 h of incubation. A450 was then measured, and the percentage of survival was calculated as follows:
IL-4 and IL-21 ELISPOT
IL-21 and IL-4 ELISPOT reagents were purchased from eBioscience, and plate coating, incubation, and development were performed according to the manufacturer's instructions. For the assays described herein, splenocytes were added to the coated plates and stimulated with CTD or OVA to a final concentration of 25 mg/ml. Cells were then incubated at 37°C for 24 h (IL-4) or 96 h (IL-21) before detection of cells secreting cytokine. Once the plates were developed, ELISPOTs were enumerated using a KS ELISPOT 4.10 reader and associated software (Carl Zeiss, Thornwood, NY, USA).
CD4 + cell and iNKT cell enrichment
Splenocytes from congenic CD45.1 + B6 mice were stained with PE-conjugated anti-B220, anti-CD8 mAb and PBS57-loaded CD1d tetramer. Anti-PE microbeads were then used in conjunction with Miltenyi LD columns to enrich CD4 + T cells by negative selection. A positive selection step was then employed in which cells were labeled with APC-conjugated anti-CD4. Cells were selected using anti-APC microbeads and an LS column. This was done according to the manufacturer's instructions (Miltenyi Biotec). Cell viability and purity was typically .90%. To enrich iNKT cells splenocytes, CD45.1 + B6 mice cells were stained with PE conjugated anti-B220, anti-CD8 mAb, anti-CD11c, anti-GR-1, and anti-CD138 mAbs and were subject to negative selection. To enrich iNKT cells, the flow through the cells was labeled with PBS57-loaded CD1d tetramer and subject to positive selection. iNKT frequency was typically ;60%. 
Adoptive transfer
Statistics
Data were analyzed using GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA). A 2-tailed Mann-Whitney U test and an ANOVA with the Bonferroni posttest were used to compare 2 and multiple experimental groups, respectively. For 1 adoptive transfer experiment, 1-sample t test was compared with a hypothetical control (titer = 1) because there were only 2 mice in the no-transfer control group. For challenge experiments, survival data were subject to Kaplan-Meier analysis with a log-rank test.
RESULTS
Contribution of iNKT cells to the protective humoral immune response against TcdB
Experiments were performed to determine whether activation of the iNKT cells enhanced the humoral immune response to TcdB. Because TcdB is toxic, with an in vivo LD 100 of 5 mg/kg (or less), of body weight [28] , the CTD fragment of TcdB, containing epitopes for Ab-mediated neutralization, was used as the immunization Ag [29] . B6 and CD1d 2/2 mice were immunized with CTD alone or with CTD plus a-GC. This was followed by administration of a booster consisting of CTD and collection of the sera for the measurement of CTD-specific IgG. CTD-specific IgG1 titers were significantly enhanced in B6 mice that received CTD and a-GC compared with those that were immunized with CTD alone (Fig. 1A) . There was no significant difference in titers observed in CD1d 2/2 mice that received CTD alone or CTD plus a-GC. There was no significant increase in the CTD-specific IgG2b or IgG2c titers following a-GC administration (data not shown). ELISAs were also performed in which plates were coated with low and high concentrations (0.1 and 1 mg/ml, respectively) of CTD to determine whether sera from the different experimental groups displayed differences in the proportion of highaffinity CTD-specific Abs. It was observed that a-GC led to a significant increase in the absorbance ratio (A405 at 0.1 mg/ml; A405 at 1.0 mg/ml) in the sera from B6 mice but not from CD1d 2/2 mice (data not shown). This method does not directly measure the affinity of the Ab, but it indicated that a-GC stimulated an iNKT cell-dependent increase in the proportion of higher-affinity Abs.
In vitro toxin-neutralization assays were performed to determine whether the a-GC-enhanced IgG1 response led to enhanced protection of cells against TcdB (Fig. 1B) . This was achieved by challenging CHO cells with TcdB in the presence or absence of sera. Sera from B6 mice immunized with CTD and a-GC showed significantly enhanced in vitro neutralization of TcdB when compared with sera from mice immunized with CTD alone (Fig. 1B) . TcdB neutralization did not differ significantly between sera obtained from CD1d 2/2 mice immunized with CTD and CTD plus a-GC (Fig. 1B) .
To determine whether immunization with a-GC enhanced protection in vivo against TcdB, naïve and immunized B6 and CD1d 2/2 mice were challenged with whole TcdB. Naïve B6 and CD1d 2/2 mice all died within 20 h (Fig. 1C) . A survival rate of 44% was observed in B6 mice immunized with CTD and 100% in B6 mice immunized with CTD plus a-GC (Fig. 1C) . In contrast, there was a 0% survival rate among naïve and CTD-immunized CD1d 2/2 mice (Fig. 1C) . The survival rate was not significantly improved by inclusion of a-GC, where time to death in 1 animal was delayed by ;28 h (Fig. 1C) . The data in Fig. 1 , therefore, show that activation of iNKT cells with a-GC leads to enhanced TcdB-neutralizing IgG1 responses, which are protective in vivo. We and others [11, 30] have previously reported that CD1d
mice lack all iNKT cells and do not respond to a-GC. Furthermore, a-GC enhances initial iNKT activation, as evidenced by secretion of several cytokines, including IL-4 and IFN-g and up-regulation of costimulatory molecules [9, 16, 31] . The effects, herein, are, therefore, attributable to iNKT cells, and their activation and function was, therefore, examined in subsequent experiments.
Priming of an anti-hapten IgG1 response following immunization with CTD plus a-GC
The sources of T lineage help following immunization with a T dependent Ag and a glycolipid adjuvant are not fully understood.
To determine whether activation of iNKT cells primes T lineagedependent help for CTD-specific B cells, mice were immunized with CTD or CTD plus a-GC and then boosted with NP-hapten-conjugated CTD before measurement of NP-specific IgG1 titers (Fig. 2) . Anti-NP IgG1 titers were significantly enhanced in sera from B6 mice that were immunized with CTD and a-GC as compared with mice that were immunized with CTD alone (Fig. 2) . There was no difference in the anti-NP titers between CTD and CTD plus a-GC-immunized Ja18 2/2 mice (mice that lack type I a-GC-reactive iNKT cells), indicating that the enhanced anti-NP Ab titers in B6 mice required iNKT cells (Fig. 2) . These data indicate that a-GC either led to enhanced priming of CTD-specific T lineage cells or caused a prolonged activation of iNKT cells that provided B cell help. This result prompted further investigation to assess the sources of T lineage B cell help following immunization with CTD and a-GC.
iNKTfh cells, but not Tfh cells, expand after immunization with a-GC
To determine whether administration of a-GC led to an expansion of Tfh or iNKTfh cells, B6 mice were immunized with CTD or CTD plus a-GC. Lymph node lymphocytes were then analyzed by flow cytometry (Fig. 3) . (Fig. 3A and C) . In contrast to Tfh cells, the frequency of iNKTfh cells, defined as CD1d tetramer iNKT cell-derived and -facilitated secretion of IL-4 and IL-21 after activation with a-GC IL-4 and IL-21 cooperate to stimulate IgG1 class-switch recombination [32, 33] . We, therefore, assessed IL-4 and IL-21 production following immunization of B6 and CD1d
2/2
mice with CTD or CTD plus a-GC (Fig. 4) . Intracellular staining for IL-4 and IL-21 can have limited sensitivity and is difficult to quantify. Therefore, an approach was developed in which mice were immunized, and then 7 d later, splenocytes were isolated and restimulated in vitro with CTD or a heterologous Ag (OVA). The numbers of IL-4-and IL-21-secreting splenocytes were then measured by ELISPOT assay (Fig. 4A) .
Immunization of B6 mice with CTD alone followed by in vitro restimulation with CTD led to secretion of IL-4 ( Fig. 4B) and IL-21 (Fig. 4C) . When B6 mice were immunized with CTD and a-GC, followed by in vitro restimulation with CTD, there was a significant increase in the number of IL-4-and IL-21-secreting cells as compared with the cells derived from the CTDimmunized group. Cultured cells from immunized mice were also left unstimulated in vitro or were stimulated with a heterologous Ag (OVA). Neither of these control conditions led to significant secretion of IL-4 or IL-21. There was no difference in the number of IL-4-and IL-21-secreting cells in splenocytes from CD1d 2/2 mice immunized with CTD or CTD plus a-GC, irrespective of the in vitro restimulation. This demonstrated that iNKT cells were required for the a-GC-enhanced secretion of IL-4 and IL-21. T lineage cells are the primary source of secreted IL-4 and IL-21 [34, 35] . Depletion of iNKT cells was, therefore, performed to determine whether they were a direct source of the a-GC-enhanced IL-4 and IL-21 secretion. As outlined in Fig. 5A , B6 mice were immunized with CTD plus a-GC; 3 or 7 d after immunization, splenocytes were split into 2 equal batches and depleted of iNKT cells or were mock depleted (achieved by omitting the CD1d tetramer-labeling step). The iNKT-depleted and nondepleted control cells were then cultured alone or restimulated with CTD before detection of IL-4-and IL-21-secreting cells by ELISPOT assay. Flow cytometry analysis was used to confirm .99% iNKT cell depletion (Fig. 5B) . There was no significant production of IL-4 in response to stimulation with CTD in vitro when cells were harvested 3 d after the in vivo immunization, (Fig. 5C, left panel) . However, the number of IL-4-secreting cells increased following CTD stimulation when cells were harvested 7 d after the in vivo immunization, (Fig 5C, right panel) . Furthermore, the number of IL-4-secreting cells at d 7 was reduced significantly by prior iNKT cell depletion.
The number of IL-21-secreting cells increased significantly in response to CTD stimulation when cells were harvested 3 d after in vivo immunization (Fig. 5D, left panel) . Depletion of iNKT cells reduced the number of IL-21-secreting cells at the d 3 time point. In contrast, although CTD in vitro significantly increased the number of IL-21-secreting cells at d 7, depletion of iNKT cells had no effect on the response (Fig 5D, right panel) .
Therefore. IL-4 was largely produced at the later time point that received cells from CTD-immunized or CTD/a-GCimmunized donors (Fig. 6B ). There was, however, a significant increase in CTD-specific IgG1 titers in mice that received CD4 + T cells vs. those that did not receive CD4 + T cells. The OVA control showed that the Th-enhanced Ab response was specific to the original immunizing Ag, with minimal Ab titers observed. The data in Fig. 6 , therefore, showed that adoptively transferred CD4 + T cells did not have an enhanced capacity for B cell help if they were derived from a CTD plus a-GC-immunized donor mouse.
Contribution of NKTfh cells to production of CTD-specific IgG1
We crossed mice expressing the Cre recombinase enzyme exclusively in CD4-expressing cells with mice in which exons 7-9 of the gene encoding the transcription factor Bcl6 were flanked by LoxP sequences [36] . In a carefully controlled study. Hollister and colleagues [36] observed that LoxP sequences did not alter Tfh differentiation in the absence of Cre recombinase, that Cre expression was specific for the CD4 compartment, and that there were no deleterious effects observed on various immune cell types other than Tfh cells.
In the present study, mice were chosen from an F2 generation that expressed Cre and in which Bcl6 was intact (Bcl6 +/+ ;Cd4-Cre + ) and mice in which Cre was expressed and Bcl6 was ablated in CD4-expressing cells (Bcl6 fl/fl ;Cd4-Cre + ). Because Bcl6 is required for differentiation of both Tfh and iNKTfh cells [18, 19] , this provided a valuable tool for determining the role of Tfh and iNKTfh cells in a-GC-enhanced humoral immunity.
Mice were immunized with a-GC and after 7 d, lymph node cells were examined by flow cytometry (Fig. 7A) + Tfh cells were also completely ablated (data not shown). This is consistent with a previous report [36] and PD-1 hi Tfh populations could be discerned, a continuum of PD-1 expression was also evident in the Hollister et al. [36] study. The maximum PD-1 expression in the Bcl6 fl/fl ;Cd4-Cre + mice was, therefore, used to demarcate PD-1 lo vs. PD-1 hi NKT cells in this study. Bcl6 +/+ ;Cd4-Cre + and Bcl6 fl/fl ;Cd4-Cre + mice were immunized with CTD or CTD plus a-GC, and CTD-specific IgG1 titers were measured by ELISA (Fig. 7B) . As expected, the anti-CTD IgG1 titers were significantly enhanced by a-GC in the Bcl6 +/+ ;Cd4-Cre + mice. In contrast, minimal or nondetectable IgG1 titers were observed in the Bcl6 fl/fl ;Cd4-Cre + mice immunized with CTD alone or CTD plus a-GC. This shows that iNKT cells incapable of iNKTfh differentiation could not provide B cell help. Adoptive transfer of iNKT-depleted naïve CD4 + T cells led to some restoration of Ab titers as did transfer of whole naïve CD4 + T cells (Fig. 7C) . Furthermore, transfer of iNKT cells resulted in variable, but partially restored, Ab titers (Fig. 7C) . These data indicate that restoring the capacity for Tfh or iNKTfh differentiation can confer limited responsiveness of Bcl6 fl/fl ;Cd4-Cre + to immunization with CTD plus a-GC.
DISCUSSION
Herein, we have examined iNKT cell-mediated B cell help in the context of classic T cells responses and demonstrated a direct role for the iNKTfh cellular subset in the iNKT-enhanced Ab response. In this study, we focused on Ab responses specific for the C. difficile TcdB-derived immunogen CTD. Consistent with CTD-specific Ab titers, immunization of B6 mice, but not -enriched NKT cells. Graphs in (B) and (C) show the endpoint of anti-CTD IgG1 titer means. Each symbol represents an individual mouse, and statistical significance is indicated by asterisks, *P , 0.05. As described in Materials and Methods, a hypothetical control titer of 1 was used for upper graph (C) due to having 2 recipients in control group.
CD1d
2/2 mice with a-GC, enhanced the production of antibodies capable of in vitro neutralization and in vivo protection against a lethal toxin challenge. These results were largely consistent with what has been observed with Ab responses against other pathogen-derived products. However, it was surprising that the survival of challenged CD1d 2/2 mice that had previously been immunized with CTD alone was much inferior to that of B6 controls. This suggests a previously unappreciated role for iNKT cells in boosting the production of neutralizing Abs even in the absence of an exogenous CD1d ligand. Arguably, iNKT cells responding to self-CD1d Ag could direct more B cells into germinal-center reactions or affect selection therein for higher-affinity B cells, which are more likely to encode neutralizing Ab. Indeed, an indirect affinity ELISA suggested that sera from B6 mice contained a greater proportion of high-affinity anti-CTD Abs than did the CD1d 2/2 mice (data not shown).
Further studies on this question were outside the scope of the present study but warrant additional investigation.
Immunization with CTD plus a-GC resulted in apparent T cell priming, as demonstrated by a higher Ab response when mice were boosted with NP hapten-linked CTD. This could be explained by iNKT activation leading to priming of classic class II-restricted Th cells that subsequently responded rapidly to a NP-CTD-derived peptide and provided rapid help for NPspecific B cells. Alternatively, activation and/or an expansion of a specialized iNKT cell subset, such as iNKTfh cells, could also explain this result because B cell help from additional sources would be available when the NP-CTD immunogen was administered.
Experiments were therefore performed to examine the T lineage help available to B cells following immunization with CTD plus a-GC. Flow cytometry analysis of Tfh and iNKTfh cells after immunization very clearly demonstrated that a-GC did not lead to an enhanced expansion of Tfh cells but did expand iNKTfh cells. Enumeration of IL-4-and IL-21-secreting cells by ELISPOT revealed that, 3 d after immunization, iNKT cells (presumably iNKTfh cells) accounted for most of the IL-21 being produced. Later in the response, at d 7, IL-21 was largely T (Tfh)-derived. In contrast, IL-4 production was more substantial at d 7 than at d 3, and it appeared that there was a contribution from iNKT/iNKTfh cells. However, we previously reported that iNKT-derived IL-4 was dispensable for a-GC-enhanced IgG1 responses [17] .
The means by which IL-4 and IL-21 secretion occurs in an Agspecific manner remains unclear. In vivo immunization most likely leads to presentation of CTD-derived peptides by class II and of a-GC by CD1d of DCs and B cells. When splenocytes are restimulated in culture, only B cells bearing CTD-specific BCR and continuing to present a-GC on CD1d would be capable of causing restimulation of DC-primed Th and Tfh cells as well as iNKT and iNKTfh cells. Although B cells specific to heterologous Ag may exist and may present a-GC on CD1d, the corresponding Ag-specific Th and Tfh cells would not have been primed in vivo and would be unable to respond to the mock restimulation.
Direct intracellular staining for IL-4 and IL-21 was attempted, but flow cytometry was not sensitive enough to detect cytokines after restimulation with CTD. Typically, this method of detection requires polyclonal stimulation with PMA/ionomycin or CD3/CD28 [37] . In addition, detection of intracellular IL-4 requires supplementation of cultures with recombinant IL-4, which provides a positive feedback for the generation of detectable intracellular IL-4 [38] . However, this method would interfere with our assays. We have been able to detect intracellular IL-4 using 4GET reporter mice. We observed that, after immunization with CTD alone or CTD plus a-GC, most IL-4-secreting cells were CD4 IL-21 is a type-I cytokine that signals via a specific IL-21 receptor (IL-21R) [39] , and the common cytokine receptor g c chain is shared by the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 [40] . IL-21 has a positive feedback mechanism to regulate its production [41] . It is, therefore, possible that iNKTfh cell-derived IL-21 can enhance IL-21 production by Tfh cells. However, if a knock-on effect of iNKTfh-derived IL-21 on Tfhderived IL-21 occurred, it did not translate into enhanced T helper function because adoptive transfer of Th cells from CTD or CTD-immunized donor mice stimulated equivalent Ab titers in CTD-immunized TCR 2/2 recipient mice. In addition, equivalent numbers of Tfh cells were induced whether a-GC was administered or not, showing that iNKT activation with a-GC had no detectable effect on the Th/Tfh compartments. To date, there are no reports, to our knowledge, on whether iNKTfh cells could contribute to autoantibody responses, although a role exists for Tfh cells in promotion of such responses [42] . We observed that a-GC did not enhance the Tfh response, which is consistent with a lack of antinuclear Ab after our a-GC immunization method (Lang, unpublished observation), and reports by other groups showing that a-GC-reactive NKT cells suppress autoimmunity [43, 44] .
Previous studies have shown that immunization of class II-null mice with a-GC was able to induce a limited Ab response against a coadministered T dependent Ag [11, 45] . Class-II null mice lack all Th cells but display normal iNKT development (and presumably normal iNKTfh differentiation). We, therefore, used lineage-specific ablation to assess the contributions of classic + T cells alone. Given that the Bcl6-ablated mice are not CD4 + T cell or iNKT-deficient, adoptive transfer may generally be limited in its ability to stimulate the level of B cell help observed in nonablated control mice. However, it does seem that iNKTfh-mediated B cell help can be detected after adoptive transfer of iNKT cells capable of iNKTfh differentiation.
In a previous study [46] , bone marrow chimeras were generated in which only iNKT cells were deficient in IL-21 secretion, and it appeared that iNKT cell-derived IL-21 was dispensable for humoral immunity after immunization with a T dependent Ag and a-GC. This could indicate that iNKTfh cells exert their effects on B cells in an IL-21-independent manner or that redundancy prevented detection of their role. Our ELISPOT experiments showed an early IL-21 secretion by the iNKT compartment complemented by later Th-derived IL-21, suggesting that both cellular sources are important during a humoral immune response.
In summary, we have demonstrated that iNKT/iNKTfh cells function largely independently but cooperatively with Th/Tfh cells after immunization with T dependent Ags and the a-GC adjuvant. As a result of these findings, our understanding of the role of iNKT and iNKTfh cells in the context of classic Th and Tfh B cell help has improved and shows that CD1d-binding glycolipid adjuvants invoke B cell help that is consequential after immunization.
AUTHORSHIP P.R. designed the experiments, performed the experiments, analyzed the data, and wrote the paper; G.A.L., T.S.D., and C.G. performed the experiments and analyzed the data; J.D.B. produced and provided unique reagents, provided expertise on C. difficile, and provided guidance on the challenge studies; and M.L.L. designed the study, analyzed the data, and wrote the paper.
